A Greco1, E Orlandi2, A Mirabile3, S Takanen4, C Fallai2, N A Iacovelli2, A Rimedio5, E Russi6, M Sala1, D Monzani1, D I Rosenthal7, G B Gunn7, P Steca1, L Licitra3, P Bossi8. 1. Department of Psychology, University of Milan "Bicocca", Milan, Italy. 2. Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. 3. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. 4. Unit of Radiotherapy, Policlinico Umberto I, University "La Sapienza", Rome, Italy. 5. Medical Ethics Committees of the Teaching Hospital "S. Croce e Carle", Cuneo, Italy. 6. Department of Radiation Oncology, Teaching Hospital "S. Croce e Carle", Cuneo, Italy. 7. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 8. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. paolo.bossi@istitutotumori.mi.it.
Abstract
BACKGROUND: Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventory--Head and Neck Module (MDASI-HN). METHODS: Following forward and backward translation of the items of the English MDASI-HN into Italian, it was administered along with a cognitive debriefing to HNC patients able to read and understand Italian language. Individual and group responses are presented using descriptive statistics. RESULTS: From May 2013 through September 2013, 56 patients with HNC (18 during curative treatment, 20 in palliative chemotherapy, and 18 in follow-up period) completed the MDASI-HN followed by accompanying cognitive debriefing. Ninety-nine percent of the individual MDASI-HN items were completed. Average time to complete the MDASI-HN was 8.5 min (range 3-15). Results suggested overall ease of completion, relevance, and comprehensibleness of this translated self-report instrument in this Italian patient population. CONCLUSIONS: The Italian version of the MDASI-HN is linguistically valid; future research should explore dimensionality, reliability, and convergent, discriminant, and predictive validity of this patient-reported instrument, in order to use this translated version in outcomes research and clinical settings.
BACKGROUND: Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventory--Head and Neck Module (MDASI-HN). METHODS: Following forward and backward translation of the items of the English MDASI-HN into Italian, it was administered along with a cognitive debriefing to HNC patients able to read and understand Italian language. Individual and group responses are presented using descriptive statistics. RESULTS: From May 2013 through September 2013, 56 patients with HNC (18 during curative treatment, 20 in palliative chemotherapy, and 18 in follow-up period) completed the MDASI-HN followed by accompanying cognitive debriefing. Ninety-nine percent of the individual MDASI-HN items were completed. Average time to complete the MDASI-HN was 8.5 min (range 3-15). Results suggested overall ease of completion, relevance, and comprehensibleness of this translated self-report instrument in this Italian patient population. CONCLUSIONS: The Italian version of the MDASI-HN is linguistically valid; future research should explore dimensionality, reliability, and convergent, discriminant, and predictive validity of this patient-reported instrument, in order to use this translated version in outcomes research and clinical settings.
Entities:
Keywords:
Head and neck cancer; Italian MDASI-HN; Patient symptoms; Patient-reported outcome
Authors: Xin Shelley Wang; Adriano V Laudico; Hong Guo; Tito R Mendoza; Maria Lourdes Matsuda; Victor D Yosuico; Edilberto P Fragante; Charles S Cleeland Journal: J Pain Symptom Manage Date: 2006-06 Impact factor: 3.612
Authors: W Yeo; F K F Mo; J Koh; A T C Chan; T Leung; P Hui; L Chan; A Tang; J J Lee; T S K Mok; P B S Lai; P J Johnson; B Zee Journal: Ann Oncol Date: 2006-04-06 Impact factor: 32.976
Authors: David I Rosenthal; Tito R Mendoza; Mark S Chambers; Joshua A Asper; Ibrahima Gning; Merrill S Kies; Randal S Weber; Jan S Lewin; Adam S Garden; K Kian Ang; Xin S Wang; Charles S Cleeland Journal: Head Neck Date: 2007-10 Impact factor: 3.147
Authors: Augusta P Silveira; Joaquim Gonçalves; Teresa Sequeira; Cláudia Ribeiro; Carlos Lopes; Eurico Monteiro; Francisco L Pimentel Journal: Head Neck Oncol Date: 2010-10-31
Authors: Mary H Sailors; Diane C Bodurka; Ibrahima Gning; Lois M Ramondetta; Loretta A Williams; Tito R Mendoza; Sonika Agarwal; Charlotte C Sun; Charles S Cleeland Journal: Gynecol Oncol Date: 2013-05-15 Impact factor: 5.482
Authors: Carrie A Karvonen-Gutierrez; David L Ronis; Karen E Fowler; Jeffrey E Terrell; Stephen B Gruber; Sonia A Duffy Journal: J Clin Oncol Date: 2008-06-01 Impact factor: 44.544
Authors: I C van der Meulen; A M May; J R J de Leeuw; R Koole; M Oosterom; G-J Hordijk; W J G Ros Journal: Br J Cancer Date: 2013-11-26 Impact factor: 7.640
Authors: Marta Maddalo; Michela Buglione; Nadia Pasinetti; Luca Triggiani; Loredana Costa; Stefano M Magrini; Barbara A Murphy Journal: Radiol Med Date: 2019-11-29 Impact factor: 3.469